Canadian Urological Association (CUA) artwork

CUA Q & A Series | Bone Health Management in Prostate Cancer - David Kendler

Canadian Urological Association (CUA)

English - April 04, 2022 04:00 - 15 minutes - 14 MB
Medicine Health & Fitness Science Life Sciences medicine urologic urology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: CUA Highlights of GU ASCO 2022 - Bladder Cancer Session
Next Episode: CUA Q & A Series | Bone Health Management in Prostate Cancer - Sophie Mottard

CUA Q & A Series | Bone Health Management in Prostate Cancer - David Kendler

Sponsored by Amgen.

Speakers:

David Kendler

Endocrinologist and Clinical Professor

UBC

 

Disclosures:

David Kendler

Advisory Board: Amgen, Paladin, Biosynt

Speakers Bureau: Amgen

Payment: Amgen, Biosynt, Radius Pharma, Paladin

Grant/Honorarium: Amgen, Biosynt, Radius Pharma, Paladin

Clinical Trial: Radius Pharma

Leadership/Board Position: Specialists of BC, Drs. of BC section of Endocrinology (executive)